Firms To Watch: Industry focus: Healthcare and life sciences

EY TAX & LAW ITALY, led by Aldo Brielli, assists clients on regulatory, administrative, liability, commercial and IP matters for clients in the healthcare and life sciences sector.

Industry focus: Healthcare and life sciences in Italy

Bird & Bird

Bird & Bird provide a complete service to its clients in the healthcare and life sciences sectors. It advises on IP, regulatory, transactional corporate, EU and competition, data protection and dispute resolution matters. Massimiliano Mostardini and Giovanni Galimberti head the practice, both focusing on IP matters affecting the sector including trademarks, copyright and unfair competition. Within the practice, Antonella De Gregori utilises her specialist knowledge in the pharmaceutical sector, and Claudia Ricciardi drafts and negotiates patent/know how licences and assignment agreements. Evelina Marchesoni and Mauro Turrini are also of note. In May 2023, Elisabetta Bandera and Rita Tardiolo were made partners.

Responsables de la pratique:

Giovanni Galimberti; Massimiliano Mostardini


Autres avocats clés:

Antonella De Gregori; Claudia Ricciardi; Evelina Marchesoni; Mauro Turrini; Elisabetta Bandera; Rita Tardiolo


Les références

‘They provide innovative ideas/solutions to complex issues. Teams properly formed with lawyers and patent attorneys. Good communication skills. Good timing in work delivery.’

‘Good knowledgeable team with sensible commercial advice.’

‘Giovanni Galimberti is very easy to work with and gives excellent commercial advice.’

Principaux clients

Alcon Italia


Astellas Pharma


Benefis


Doctolib


Fisher & Paykel


Gruppo San Donato


Heska Corporation


INCIPIT


Istituto Europeo di Oncologia


ISchema View


Kyowa Kirin Italia


Multimedica Clinical & Research Campus


Permedica


Polpharma group


San Donato Group


San Raffaele Hospital


Swiss Pharma International


Telethon Foundation


Principaux dossiers


  • Assisted Instituto Nazionale Genetica Molecolare in connection with the conferment of a patent in T-One Therapeutics, a newly established company in which the Utopia Fund invested.
  • Assisting Swiss Pharma International in invalidity proceedings before the Court of Rome, related to a patent claiming a dosage regimen of the active ingredient natalizumab for the treatment of multiple sclerosis owned by Biogen.
  • Assisted Gruppo San Donato in the creation of a contractual joint venture with Microsoft for the creation of an AI Center of Excellence for the development of artificial intelligence systems to treat certain type of cancers and other clinical projects.

BonelliErede

The multidisciplinary practice at BonelliErede assists its clients in the healthcare and life sciences sectors in all manner of matters. The firm has deep knowledge of the pharmaceutical and biomedical markets, advising on matters involving EU and competition law, litigation, administrative issues, M&A, IP and tax. Other notable members within the practice include managing partner Andrea Carta Mantiglia, who specialises in M&A, litigation and international arbitration within the sector, and IP specialist Giovanni Guglielmetti. Sarah Lembo‘s broad expertise includes a focus on EU and anti-trust law. Vincenzo Salvatore left the practice in March 2024.

Autres avocats clés:

Sarah Lembo; Andrea Carta Mantiglia; Giovanni Guglielmetti


Les références

High experience, broad capabilities and different expertises inside the BE team that can support in complex projects/discussions. Flexible and smart in finding the right solution for the customer (adapting to customer needs). Reactive and fast when there is urgency.’

Principaux clients

Amylyx Pharmaceuticals


Bausch & Lomb


Biogen


Bracco Imaging


Chiesi Farmaceutici


CSL Behring


Dompé


Gilead


Immunogen


Luxottica


Kedrion


Novartis


Novocure


Pfizer


Pharming Group


Pikdare


Recordati


Roche


Principaux dossiers


  • Assisting Biogen in challenging the approval of a generic medicine, the sale of which could constitute an anti-competitive measure for Biogen.
  • Assisted Amylyx Pharmaceuticals during the assessment procedure before the EMEA CHMP for the launch of an innovative drug for AML.
  • Providing Pharming Group with ongoing legal support on regulatory aspects and the drafting of commercial contracts (e.g. sponsorship agreements).

DLA Piper

DLA Piper’s healthcare and life sciences practice spans the sector, with experience in corporate, regulatory, public procurement, privacy, IP, competition and litigation. The firm advises major players in the industry, including national and multinational pharmaceutical corporations, on domestic and cross-border matters. Roberto Valenti is the head of the department at the firm; he advises on IP litigation and commercial matters in the life science sectors, with particular expertise on matters involving medical devices. Marco de Morpurgo focuses on the EU and national regulation of pharmaceuticals, biotech and medical devices.

 

Responsables de la pratique:

Roberto Valenti


Autres avocats clés:

Marco de Morpurgo


Les références

‘The team is well prepared, open and available to specific requests. They are also skilled at managing discussions and talented. ’

‘Empathetic and personalized customer management.’

‘Acumen, sophistication, and the ability to interpret not only the laws but also environmental situations.’

Principaux clients

Pfizer Inc.


GlaxoSmithKline


Iovance Biotherapeutics


Vertex Pharmaceuticals


Essity


Sifi


Menarini Group


Medtronic


Reckitt Benkiser


GE Healthcare


Principaux dossiers


  • Advised Pfizer Inc. with regard to the agreement for the supply of their Covid-19 Vaccine across Europe.
  • Assisting Medtronic Inc. in a patent dispute among European leading manufacturers and suppliers of a range of medical devices for respiratory support, in connection with the alleged infringement of two European patents referred to devices for oxygen administration in the intensive therapy.
  • Assisted Sifi S.p.A. in the implementation of the license agreement regarding SIFI IP (including a patent which is crucial for the manufacture of the product) for the manufacturing and marketing of intra-ocular lenses and other surgical devices for the treatment of eye diseases in Greater China.

Herbert Smith Freehills

Herbert Smith Freehills assists clients on matters across the healthcare and life sciences spectrum, such as IP disputes, regulation and compliance issues, white-collar crime investigations, clinical trials, privacy issues and financings. Managing partner Laura Orlando leads the practice alongside assisting clients in IP-related healthcare and life sciences matters, with a particular focus on patent litigation in the pharmaceutical, biotech and chemical sectors. Within the team, Sara Balice assists clients in matters concerning patents, trademarks, copyright, design, unfair competition and trade secrets. In February 2023, Augusto Santoro joined the firm from Simmons & Simmons.

Responsables de la pratique:

Laura Orlando


Autres avocats clés:

Sara Balice


Les références

‘Really business oriented and proactive.’

‘This is a firm that really does have outstanding commercial knowledge of the industry.’

‘They are genuine business partners with a very innovative approach to advising clients.’

Principaux clients

Abbott


Abbvie


Achilles Vaccines


Biogen


Eli Lilly


Janssen


Lionhealth Srl


Lundbeck


Millennium Pharmaceuticals (Takeda)


Novaliq


Pharma Prime


Philips S.p.A.


Roche


Sanofi


The US Government


Veterna


Zambon


Principaux dossiers


Hogan Lovells International LLP

Hogan Lovells International LLP combines practices to ensure all matters arising in the healthcare and life sciences industries can be dealt with, including M&A, commercial, regulatory, product liability, IP, compliance and litigation. The firm also maintains a good relationship with the Italian health authorities. The practice is led by Christian Di Mauro, who has a focus on product liability, safety, compliance and regulation. Within the healthcare and life sciences department, Giuseppe Aminzade is highly knowledgeable in pharmaceutical law, medical liability and administrative law affecting the industry. Chiara Perolari is also noted for her assistance in regulatory matters and clinical trial support.

Responsables de la pratique:

Christian Di Mauro


Autres avocats clés:

Giuseppe Aminzade; Chiara Perolari


Les références

‘Giuseppe Aminzade is a strategically thinking attorney who always sees the full picture.’

‘Good knowledge about medical devices and its business practices.’

‘Christian di Mauro is an excellent lawyer. His whole team is provides excellent support.’

Principaux clients

Angelini Holding


Baxter AG, Baxter S.p.A


CHR Hansen Italia


Eli Lilly


Fidia Farmaceutici S.p.A.


Formula Pharmaceuticals Inc.


GE Healthcare


Grünenthal


Livanova PLC


Orthofix


Qiagen Marseille


Recordati S.p.A.


Sorin Group


Takeda Shire


Principaux dossiers


Portolano Cavallo

Portolano Cavallo advises major healthcare and life sciences clients on transactional/contractual, IP, compliance and regulatory, product liability and litigation matters. Luca Gambini and Elisa Stefanini lead the practice group. Gambini has a particular strength in M&A transactions relating to the life sciences sector, whilst Stefanini focuses on regulatory and compliance matters for pharma, biotech and med-tech clients. Andrea Gritti joined the firm from Gianni & Origoni in March 2023, with Gianpaolo Scandone following from Gatti Pavesi Bianchi Ludovici in June 2023. In July 2023, Enzo Marasà was promoted to partner.

Responsables de la pratique:

Elisa Stefanini; Luca Gambini


Autres avocats clés:

Andrea Gritti; Gianpaolo Scandone; Enzo Marasà


Les références

‘Fully reliable team; technically expert; innovative entrepreneurial approach.’

‘Independent firm able to mobilize resources while innovating in its services.’

Fully reliable team with a cost effective approach, technically expert, innovative Entrepreneurial approach Independant firm able to mobilize resources while innovating in its services.’

Principaux dossiers


  •  
     

ADVANT Nctm

ADVANT Nctm assists the full range of actors in the healthcare and life sciences sector, from manufacturers and pharmaceutical companies to regulators, investors and public-private partnerships. The firm draws talent from across departments to cater to each matter, be it IP, anti-trust or administrative. The two heads of the healthcare and life sciences practice are Lorena Possagno, who focuses on corporate and commercial assistance, and Paolo Gallarati, who specialises in international transactions and compliance in life sciences. In 2023, both Jacopo Arnaboldi and Giulio Uras were promoted to partner.

Responsables de la pratique:

Lorena Possagno; Paolo Gallarati


Autres avocats clés:

Jacopo Arnaboldi; Giulio Uras


Les références

‘The team is professional and responsive. They put client’s interest as top priority in negotiations.’

‘The partner Lorena Possagno plays a critical role in projects and helps non-EU client understand EU listing regulations.’

‘Extremely supportive, professional, dynamic and decisive team.’

Principaux clients

Astrazeneca S.p.A.


Fresenius Group


Gilead Sciences S.r.l.


Doc Generici S.r.l.


Genetic S.p.A.


Aboca


Allovir Inc.


Circassia Pharmaceuticals Ltd


Uriach Italy


Opocrin S.p.A.


Astrazeneca S.p.A.


Ream SGR S.p.A.


Gilead Sciences S.r.l.


Doc Generici S.r.l.


Genetic S.p.A.


Advanced Medtech


Principaux dossiers


  • Assisting Fresenius Group in relation to a wide array of legal services, such as a) dealing with AIFA and Public Administration; b) IP issues/intellectual property protection; c) legal issues related to compliance topics; d) legal issues related to employment agreements and labour topics; and e) corporate governance.
  • Assisted Mediolanum Farmaceutici in relation to the sale of an undisclosed percetange of Neopharmed Gentili, another Italian pharmaceutical company owned also by French Private Equity fund Ardiani and by Del Bono family to the Luxembourg Private Equity fund NB Renaissance. Value: EUR 1,5 billion.
  • Assisting AstraZeneca S.p.A. in relation to data protection matters.

Studio Professionale Associato a Baker & McKenzie

Studio Professionale Associato a Baker & McKenzie’s expertise stretches across the healthcare and life sciences sector with the ability to advise on regulatory, compliance, IP, clinical trials, disputes and administrative issues. The firm is experienced with the plethora of contentious issues that may affect its clients. Roberto Cursano leads the firm’s healthcare and life sciences practice. He frequently assists clients with regulations, contract law, pricing, clinical trial, public procurement and anti-bribery matters. Within the practice, Mario Cigno is noted for advising clients on regulatory matters, including public tender, clinical investigations and recalls.

Responsables de la pratique:

Roberto Cursano


Autres avocats clés:

Mario Cigno


Les références

‘They are all really top quality.’

‘The individuals are excellent.’

‘Baker’s team is remarkable insofar that they are always available, pleasant to work with and multi-facetted. On top, while providing sound legal advise and risk assessment, they remain pragmatic and solution oriented.’

Principaux clients

Regeneron Pharmaceuticals


ICU Medical Group


Ecolab


Abbott S.r.l.


Hartmann Group


Intervet


Crossmed


Integra Lifesciences


Organon


PerkinElmer


Wolters Kluwer Health Inc.


Vyaire


Meridian Bioscience


Quadrel


Bio-Rad Laboratories


Illumina


Applied Medical


Seqirus


Principaux dossiers


  • Assisting several med-tech companies, amongst which, ICU Medical Group, Hartmann Group, Crossmed S.p.A., Integra Lifesciences, Vyaire, Meridian Bioscience, Bio-rad Laboratories, Illumina and Applied Medical in the context of legal proceedings, for an overall value of millions of Euro, to challenge payment orders issued by Italian authorities pursuant to the Italian legislation on the payback for medical devices.
  • Assisting Regeneron on a wide range of regulatory, corporate and commercial matters related to the incorporation of a new legal entity in Italy in connection with a global expansion project.
  • Assisting Intervet, a company of Merck group, in connection with the acquisition of several plots of lands in the area of Aprilia (Rome), to be used as an industrial site by the company.

Chiomenti

Chiomenti maintains a dedicated multidisciplinary team for the healthcare and life sciences industry. It regularly advises on acquisitions and broader corporate matters in addition to areas such as tax planning, compliance and anti-trust. Its clients range from pharma manufacturers, research companies and producers of medical devices to companies that offer healthcare and hospital services. Luca Liistro leads the practice group whilst assisting clients on corporate and commercial matters. Filippo Brunetti advises on a range of corporate matters, pricing and market access together with compliance issues (he liaises with various authorities such as the Italian Pharmaceutical Agency. Corporate/M&A specialist Francesca Villa includes a number of pharma and medtech companies among her clients.

Responsables de la pratique:

Luca Liistro


Autres avocats clés:

Filippo Brunetti; Francesca Villa


Les références

‘Very sound knowledge of the HC and life science sector. Pro-active approach. Very reliable. Super competent.’

‘Strong expertise in the health sector which is highly regulated; proactive approach anticipating potential issues/concerns.

‘Luca Liistro has a strong commitment and is business oriented.’

Principaux clients

Abbott S.p.A.


Air Liquide Sanità Service


Albis International


Alfasigma


Amplifon


Artsana


BioNTech


BioVelocITA


Carestream Dental Italy


Coloplast


Columbus Education Association


Fidia Farmaceutici S.p.A.


Forest Laboratories


Gilead Sciences


Groupe Simago SAS


Khiron


Laboratoires Expanscience


Lifebrain Group


LifeNet Health


Menarini Group


Merck Sharp & Dohme (Italia)


M.I.T. Italia S.r.l.


Neuraxpharm


Recordati


Roche S.p.A.


SoBi Pharma


Sophia Genetics


Surmodics


Techwald Holding


Xvivo Perfusion


Zambon Group


Zobele


Principaux dossiers


  • Advising Alfasigma S.p.A. in relation to the acquisition of the entire corporate capital of Sofar S.p.A., an Italian pharmaceutical company active in the research, production and marketing of drugs, medical devices and dietary supplements and specialized in the gastrointestinal area.
  • Advising Groupe Simago SAS, a leader group in the imaging diagnostic in France, in its first investment in Italy through the acquisition of the entire corporate capital of Gemini2 S.r.l., a local Italian imaging diagnostic company.
  • Advising Fidia Farmaceutici S.p.A. in relation to the acquisition from Sanofi Aventis of pharmaceutical assets.

Dentons

Dentons advises clients from all sides of the healthcare and life sciences sector, including public and private bodies. The firm leverages its multidisciplinary practice to draw the requisite expertise for each matter brought by a client, from corporate to administrative. The head of the practice is Luca Pocobelli, who is greatly experienced in assisting major domestic and international clients on corporate and M&A matters related to healthcare and life sciences. Within the practice, Ilaria Gobbato advises clients through public procurement procedures and project financing.

Responsables de la pratique:

Luca Pocobelli


Autres avocats clés:

Ilaria Gobbato


Les références

‘Real dealmakers, without exposing clients to hidden risks; full practice coverage; hands-on attitude; 100% committed to the client; excellent network in the life-science industry (Italy and abroad).’

They know very well the market and they can offer always a good balance between cost and result.’

‘The strengths are certainly the speed of responses and the possibility of having experienced professionals in different fields within the same firm.’

Principaux clients

Johnson & Johnson


Fujifilm Italia


Cerba HealthCare


ArchiMed SAS


Alliance Medical


Quinta Capital SGR


Amdipharm (Advanz Pharma)


Newron Pharmaceuticals


Affidea


Principaux dossiers


  • Advising Cerba HealthCare, a leading group that invests in the laboratory diagnostics sector across Europe, on several acquisitions (more than 200 in 2014 – 2023 period), including the recent acquisition of Centro Diagnostico Gamma S.r.l., a laboratory group operating in Calabria.
  • Assisting ArchiMed, a French private equity fund focused on the healthcare industry, in connection with the sale of Micromed Holding SAS, a global provider of neurophysiology solutions, to Natus Medical Incorporated, a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders.
  • Assisting Alliance Medical, a European leading diagnostic imaging company, in relation to the acquisition of Luccioli, a company operating a major multi-specialty medical and diagnostic centre in Italy.

Gitti and Partners

Gitti and Partners centres IP and regulatory work within its healthcare and life sciences practices. In addition, the firm functions as a one-stop-shop for its clients, assisting with corporate and M&A, commercial, data protection, administrative, employment and litigation matters. Its clients include domestic and international corporations with interests inside Italy. Paola Sangiovanni is the lead for life sciences with a focus on commercial, corporate and regulatory matters, including acquisitions, licence agreements and the drafting and negotiation of contracts. Flavio Monfrini  is a key team member, advising life sciences and new technology clients on corporate and commercial law and regulatory issues.

Responsables de la pratique:

Paola Sangiovanni


Autres avocats clés:

Flavio Monfrini


Les références

‘Great professionalism, preparation in every legal area and professional conduct based on profound ethics and attention to customer needs.’

‘Paola Sangiovanni has great preparation and professionalism as well as a profound capacity for mediation and humanity.’

‘The team is always helpful and professional. You can count on many professionals who specialize in every subject of business.’

Principaux clients

Nihon Kohden


Albireo Pharma Inc.


Emergent Biosolutions Inc.


Huvant S.r.l.


Principaux dossiers


  • Assisting Albireo Pharma and Emergent Biosolutions in the corporate transactions resulting in the sale of their business.
  • Litigating high profile cases against the Ministry of Health, Italian regions and the Italian Data Protection Authority on behalf of Artivion, Stago and Medtronic.
  • Assessing complex regulatory questions for Haemopharm Biofluids (Mozarc), Novartis, 3M Health Care, AirLiquide, Goodwin Procter, Shionogi and the fund Clessidra.

Orrick, Herrington & Sutcliffe

Orrick, Herrington & Sutcliffe provides a full coverage of the healthcare and life sciences sector, advising on competition, M&A, commercial agreements, regulatory, data protection, litigation and white-collar crime matters. The firm’s capabilities also include supporting domestic and international firms with cross-border matters. Jean-Paule Castagno is experienced in white-collar crime matters, including litigation and crisis management. Attilio Mazzilli assists clients through corporate and M&A - advising on major pharmaceutical transactions. Pietro Merlino left the practice for Legance - Avvocati Associati in November 2023.

Responsables de la pratique:

Jean-Paule Castagno; Attilio Mazzilli


Les références

‘Very helpful and cooperative.’

‘Always attentive to the company’s best interests: Andrea Alfonso Stigliano, Livia Maria Pedroni, Attilio Mazzilli.’

Principaux clients

F. Hoffmann-La Roche SA


Kedrion – Sestant Internazionale


Healthware Group S.r.l.


Bianalisi S.p.A.


Cerba HC Italia S.r.l.


Allelica S.r.l.


Garofalo Health Care S.p.A.


Artsana Group


1000Farmacie


Principaux dossiers


  • Assisted Kedrion and its parent company Sestant Internazionale on the global merger control aspects (except the US) of a complex transaction whereby PE fund Permira and Sestant acquire joint control over Kedrion – currently solely controlled by Sestant – and Bio Products Laboratory Limited.
  • Assisted Philogen S.p.A., an Italian-Swiss company active in the biotechnology sector, for all negotiation aspects – including the IP profiles – concerning the licensing agreement with Sun Pharmaceutical Industries Limited for commercializing Philogen’s specialty product, Nidlegy™ (Daromun) in the territories of Europe, Australia and New Zealand. Nidlegy™.
  • Advised 1000 Farmacie, an Italy based company that operates an online shopping platform intended to offer a wide range of pharmaceutical products, in its €15 million financing.

Osborne Clarke

Osborne Clarke assists clients from across the healthcare and life sciences sector on major and complex M&A deals as well as on competition law. The firm is also well-versed in supporting clients through IP, regulatory and compliance matters. Maria Grazia Medici is the head of the life sciences team at the firm and specialises in the regulation of pharmaceutical products, active substances and medical devices. Within the team, Giulia Verusio provides experience in corporate and commercial law as well as pharmaceutical litigation.

Responsables de la pratique:

Maria Grazia Medici


Autres avocats clés:

Giulia Verusio


Les références

‘Giulia Verusio is an outstanding and valuable business partner to our company. She has never failed to provide us with business minded and legally sound advice.’

‘It’s evident that their team is not just well-versed in legal matters but also possesses a profound knowledge of the science and technology that underpins the sector. This unique blend of legal expertise and scientific acumen is a game-changer for anyone operating in the life sciences field.’

‘Giulia Verusio demonstrates an excellent preparation and knowledge of the health/science sector and is superb in giving her advice and managing the whole case.’

Principaux clients

Actavis Italy S.p.A.


Dentsply Sirona Italia S.r.l.


Euroapi Italy S.r.l


Grifols Italia S.p.A.


Havas PR Milan S.r.l.


Health Italia S.p.A.


Progenika Biopharma S.A.


Sciterion S.r.l.


SDM Società Dietetica Medica S.r.l.


Sic. Or. S.r.l.


TEVA Italia S.r.l.


Principaux dossiers


  • Advising Grifols Italia on successfully appealing two “photographic tenders” before the Regional Administrative Court of Lazio, leading to annulment of restrictive rules.
  • Advising on the management of the requests for repayment of exceeding medical devices expenditure at national and regional levels for the years 2015 through 2018.
  • Advising Professional Case Management Clinical Trials, LLC and PCM Clinical Trials International, Ltd on the development of new models for decentralised clinical trials outside the United States.

Pavia e Ansaldo

Pavia e Ansaldo has longstanding experience in the healthcare and life sciences sector, and it maintains active communication with globally significant regulatory bodies including the European Medicines Agency and the US Food and Drug Administration. The firm is expert in advising major pharmaceutical and biotechnology clients on IP litigation, regulatory, M&A, competition and data protection matters with an international element. Gian Paolo Di Santo leads the firm’s life sciences practice alongside his IP litigation, corporate and regulatory work for leading multinationals in the life sciences industry.

Responsables de la pratique:

Gian Paolo Di Santo


Principaux dossiers


Trevisan & Cuonzo

Trevisan & Cuonzo is noted for its expertise in litigation assistance connected to the pharmaceutical, biotech and medical devices sectors - all areas in which managing partner Gabriel Cuonzo is highly experienced. Donatella Capelli is well-versed in patent litigation and regulation, while Daniela Ampollini assists foreign and domestic clients in IP matters with a focus on the pharmaceutical and medical devices sectors. Luca Pellicciari supports clients through the regulatory aspects concerning pharmaceutical production and Federica Bocedi is also of note.

Responsables de la pratique:

Gabriel Cuonzo; Donatella Capelli; Daniela Ampollini; Luca Pellicciari


Autres avocats clés:

Federica Bocedi


Principaux dossiers


Franzosi Dal Negro Setti

Franzosi Dal Negro Setti provides assistance at every point of the pharmaceutical product chain and other life sciences matters. The firm’s clients include multinational companies as well as smaller domestic clients. Francesco Setti is known for his mastery of pharmaceutical and healthcare law and regulations, while Stefano Giberti is very experienced in advising on the pharmaceutical and medical devices sectors, including on payback and administrative disputes. In addition, Francesca Libanori complements the practice with her deep knowledge of pharmaceutical regulation. In December 2023, Vincenzo Jandoli left the practice for Lexsential.

 

Responsables de la pratique:

Francesco Setti; Stefano Giberti; Francesca Libanori


Principaux dossiers


Gianni & Origoni

Gianni & Origoni assists its healthcare clients in the broad range of matters that arise in the sector, including acquisitions, licences, IP disputes, antitrust issues and labour matters. Its clients include pharmaceutical and biotech and medical device companies and public healthcare companies. Rosario Zaccà, the lead of the healthcare and life sciences practice, is well-versed in corporate and M&A, commercial, private equity and joint venture matters with a multi-jurisdictional element. In March 2023, Andrea Gritti departed the firm for Portolano Cavallo.

Responsables de la pratique:

Rosario Zaccà


Principaux clients

Alchimia Sgr


ArchiMed S.a.S


Aspen


Biofarma Group


Fondazione Luigi Maria Monti, owner of Istituto Dermopatico dell’Immacolata (IDI – IRCCS)


GE Medical System Italia


Herbalife Italia


Hippocrates Holding


Isagro


Leadiant Group


Livanova


Medac GmbH


MSD


Novartis AG / Novartis Farma


Novo Nordisk


Orthofix


Pentaferte


Polygon


Sanofi Aventis


Takeda Italia


Sharon Laboratories


Zambon Group


Principaux dossiers


  • Advised in the litigation before the TAR Lazio against the decree of 6 July 2022 by which the Minister of Health quantified the reimbursement following the breach of the expenditure ceiling for medical devices for the years 2015, 2016, 2017 and 2018 and the decisions by which the Regions quantified the amounts to be paid by individual companies.
  • Advised Keensight Capital, one of the leading private equity managers dedicated to pan-European Growth Buyout1 investments, in the acquisition of a majority stake in Axxam, a leading innovative Partner Research Organization in the life sciences industry.
  • Advised Panakès Partners sgr, Italy’s leading venture capital firm in the life sciences sector, in setting up and launching the ‘Purple’ alternative investment fund, which reached hard cap at final closing with a fundraising of EUR 175 million.

LCA Studio Legale

LCA Studio Legale maintains a wide focus of practice, with experience advising in pharmaceutical, biotech, medical devices, healthcare, clinical trials, regulatory, M&A and litigation matters. Agostino Migone de Amicis is one of the heads of the healthcare and life sciences practice at the firm and regularly advises on corporate and regulatory matters with a particular focus on clinical trials. Andrea Carreri, the other practice head, is also noted for his assistance in pharmaceutical matters.

Responsables de la pratique:

Andrea Carreri; Agostino Migone de Amicis


Les références

‘LCA Studio Legale demonstrates an extremely high level of expertise in the field of healthcare practice.’

‘This practice is made unique by the team leader, Agostino Migone.’

‘Agostino Migone has incredible experience.’

Principaux clients

APT S.r.l.


Bausch & Lomb-IOM S.p.a.


Dealfa S.r.l.


Didofà S.r.l.


Extractum Pharma Zrt


Gargofalo Health Care S.p.A.


GSK Vaccines S.r.l.


Habilita S.p.A.


Incyte Biosciences Italy S.r.l.


Instrumentation Laboratory S.p.A.


Janssen-Cilag S.p.A.


Kaneka Corporation (Japan)


Med Consulting S.r.l.


Suanfarma S.A.


Zentiva Italia S.r.l.


Principaux dossiers


  • Representing Dealfa S.r.l., a leader in the marketing of special bandages and wound plasters, before the Administrative Court of Rome with regard to an appeal against the Italian payback system applicable to medical devices.
  • Advising the joint venture on the 30-year project financing concession for the design, construction and management of the Cittadella Sanitaria of the Treviso Hospital, which includes the construction of the Ca’ Foncello Hospital in two phases, the first of which has been completed.
  • Advised Garofalo Health Care S.p.A. on the acquisition of a 90% stake in Sanatorio Triestino S.p.A., which operates the oldest hospital in Friuli Venezia Giulia Region (in Trieste).

Legance - Avvocati Associati

Legance – Avvocati Associati assists foreign and domestic clients from across the sector, including hospitals, pharmaceutical and biotech companies. The firm maintains a strong expertise in the industry’s regulatory framework as well as matters involving corporate, IP, compliance, administrative and competition law. Giovanni Nardulli  is the firm’s head of practice and focuses his work on M&A matters, especially involving cross-border transactions. Pietro Merlino joined the firm in November 2023 from Orrick, Herrington & Sutcliffe.

Responsables de la pratique:

Giovanni Nardulli


Autres avocats clés:

Pietro Merlino; Lorenzo Gentiloni Silveri


Les références

‘The team is outstanding and responds promptly and accurately to all requests.’

‘Quality of the work and availability.


Principaux clients

Agilent Technologies


Allergy Therapeutics


Amplifon


Castello SGR S.p.A.


C.O.T. Cure Ortopediche Traumatologiche S.p.A.


Diamante S.r.l.


DWS


Entangled Capital SGR


Eusphera


LIRH Foundation


GB Pharma


GKSD Parking S.r.l


Gruppo San Donato


Gruppo San Donato East Europe


Gruppo Villa Maria


GSD Healthcare


Haemonetics


Hippocrates Holding


IRCCS Ospedale San Raffaele


IRCCS Policlinico San Donato


Kolinpharma S.p.A


KOS Group


Medipass S.p.A.


MSD Italia


Ospedale Galeazzi S.p.A.


PRP


RiverForce Partners


Teva Italia


UnipolSai


U.G.A. Nutraceuticals


Università Vita-Salute San Raffaele


Principaux dossiers


  • Assisted UnipolSai in the acquisition, from the L-GAM investment fund, of the entire share capital of Società e Salute, a company operating in the private healthcare sector under the brand name Centro Medico Santagostino.
  • Assisted Ospedale San Raffaele (Scientific Institutes of Hospitalisation and Care (IRCCS)) and Università Vita-Salute San Raffaele for a partnership for the implementation and development of a neurotechnology laboratory, the Europe’s largest of Walk Again Project.
  • Assisted PRP in entering into an investment agreement and a shareholders’ agreement with Speira Quattro (a company ultimately controlled by Hyle Capital Partners SGR), in order to promote a voluntary tender offer for the entirety of Kolinpharma’s shares – through a special purpose vehicle in which PRP will reinvest its majority shareholding following the completion of the offer – aimed at delisting the company.

LS CUBE Studio Legale

LS CUBE Studio Legale maintains a focused practice in commercial, corporate and regulatory matters in life sciences. Paola La Licata has a wealth of experience in regulatory, compliance and commercial matters connected to the life sciences sector. Rosanna Sovani is noted for her market access expertise in the industry. Paolo Ricci focuses his life sciences practice on commercial, corporate and M&A matters. Massimiliano Marinozzi is also noted for his work in mass litigation.

Responsables de la pratique:

Paolo Ricci; Paola La Licata; Massimiliano Marinozzi; Rosanna Sovani


Les références

‘A boutique firm with committed partners and associates who accompany the clients through the collaboration. A solid government relations and public policy practice which adds up to the legal questions that are being addressed.’

‘Paolo Ricci has a strategic mindset that helps addressing legal issues with a business perspective.’

‘Paola La Licata has in-depth knowledge of regulatory framework for medical devices and pharmaceutical products that provides insights into policy and legislative changes.’

Principaux clients

Actial Farmaceutici


AISF


Agave


Amarin


Amnesty


Arkopharma


Bristol Myers Squibb


Covington & Burling LLP


Celgene


Daiichi Sankyo


Diasorin


Exact Sciences


Gilead


Grant Thorton


Janssen


HRA


IBSA Farmaceutici


Kyowa Kirin


Manni Oil


Novartis


Ospedale Bambin Gesù


OTI


PharmaExtracta


Pfizer


Roche


San Raffaele IRCS


Sanofi


Schwabe


Stallergenes


TransMedics


Urgo Laboratories


Vifor


Vertex Pharmaceutical


Principaux dossiers


  • Assisted in a judicial proceeding aimed at challenging the insertion in the transparency list managed by the Italian Agency of Pharmaceutical Products of one of the main products commercialized by the company, being a narcotic product for the treatment of the ache of terminally ill cancer patients.
  • Assisted in the funding of the National Oncologic Plan with a specific funding of the Cancer Regional Network (Reti Oncologiche Regionali) and the provision of an innovative regional resource allocation mechanism based on the upon the achievement of certain goals.

Masotti Cassella

Masotti Cassella is accustomed to advising clients in a range of sectors, including medical devices, biotech and pharmaceuticals. The firm also advises on research and development and clinical trial agreements. Luca Masotti co-heads the firm’s life sciences department where he utilises his experience on corporate and M&A matters, including those involving international transactions. Joint co-head Carlo Piatti, is advises on banking, commercial, corporate, public law and litigation matters.

Responsables de la pratique:

Luca Masotti; Carlo Piatti


Principaux clients

Ab Medica S.p.A.


Pharmalex GmbH


Glenmark Pharmaceuticals


Ab Medica France


Principaux dossiers


  • Advising Pharmalex on the Italian aspects of the 1.2 billion dollar sale of its shares to AmersourceBergen.
  • Advising Glenmark on the acquisition of 100% shares in Sintesy Pharma SRL (cross-border transaction – Italy, Switzerland, India).
  • Defending one of our most important clients in a complex series of procedures (value: over 18 million Euro) challenging a decision of the Italian Government which was based on an unprecedented and very controversial law recently issued in Italy, that has already raised a large number of litigations started by medical device companies, as well as several debates on a national level, with extensive media coverage.

PedersoliGattai

PedersoliGattai maintains a dedicated specialist healthcare and life sciences group. It advises on corporate and regulatory matters that may be contentious or non-contentious. The firm serves clients from the pharmaceutical, biotechnology and medical devices sectors. Luca Saraceni, who is expert in advising a broad spectrum of clients on M&A transactions in the healthcare and life sciences industry, leads the practice alongside Sergio Fienga, who is experienced in administrative and regulatory matters.

Responsables de la pratique:

Luca Saraceni; Sergio Fienga


Principaux clients

Vista Vision


Affidea


Advanced Sterilization Products Italia


Astidental Bquadro


Epilate


Hollycon Italy


NTP Nano Tech Projects


NMS Group


Fondazione EBRI (European Brain Research Institute)


Principaux dossiers


  • Assisting the shareholders of Plurima in the agreement between Poste Italiane and Opus, owned by the Marconi family, and private equity firm Siparex for the acquisition of a majority stake in Plurima, a leading Italian logistics company for the medical sector.
  • Assisted EXOR in the acquisition of a co-controlling interest in Lifenet, a company active in the healthcare sector in the management of hospitals and outpatient clinics, through the purchase of a shareholding from the majority shareholder, Invin, and the subscription of a capital increase of Lifenet, reserved for subscription to EXOR.
  • Assisted Astidental Bquadro, an Italian company specialising in the distribution of equipment and items for dentists, dental laboratories and dental clinics, in the sale of the majority stake in the company to Gioconda, the Italian branch of LBO France, through Small Caps Opportunities II fund.

Simmons & Simmons

Simmons & Simmons leverages its strength in IP matters on a domestic and international level in the healthcare and life sciences industry. The healthcare and life sciences practice is led by Stefania Bergia, who assists clients on domestic and international IP matters as well as competition and arbitration cases, and Giulio Enrico Sironi, who is experienced in contentious and non-contentious IP matters with an international element. The team has recently seen the arrival of European health and life sciences regulatory specialist Vincenzo Salvatore, who brings valuable expertise in EU life sciences regulation and compliance, advising clients on intricate matters related to pharmaceutical and medical products. Augusto Santoro left the firm in February 2023 for Herbert Smith Freehills.

Responsables de la pratique:

Stefania Bergia; Giulio Enrico Sironi


Autres avocats clés:

Vincenzo Salvatore


Les références

Very proactive collaboration, well organized team, timely and detailed exchanges.’

‘Really strong team in Italy, particularly Stefania.

 

Principaux dossiers